Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial - The Lancet - My Upa My Jiwa Trending story found on www.upajiwa.com My Upajiwa [Source: www.upajiwa.com] [ Comments ] [See why this is trending] Share on Facebook Share on Twitter
Comments